FDA approves Opdivo, Yervoy combo for previously untreated unresectable MPM
This approval is based on a pre-specified interim analysis from the Phase 3 CheckMate -743 trial in which Opdivo + Yervoy (n=303) demonstrated superior overall survival (OS) versus